Protection of Mice against Experimental Cryptococcosis by Synthesized Peptides Delivered in Glucan Particles
ABSTRACT The high global burden of cryptococcosis has made development of a protective vaccine a public health priority. We previously demonstrated that a vaccine composed of recombinant Cryptococcus neoformans chitin deacetylase 2 (Cda2) delivered in glucan particles (GPs) protects BALB/c and C57BL...
Main Authors: | Charles A. Specht, E. Jane Homan, Chrono K. Lee, Zhongming Mou, Christina L. Gomez, Maureen M. Hester, Ambily Abraham, Florentina Rus, Gary R. Ostroff, Stuart M. Levitz |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2022-02-01
|
Series: | mBio |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/mbio.03367-21 |
Similar Items
-
Vaccination with Recombinant <italic toggle="yes">Cryptococcus</italic> Proteins in Glucan Particles Protects Mice against Cryptococcosis in a Manner Dependent upon Mouse Strain and Cryptococcal Species
by: Charles A. Specht, et al.
Published: (2017-12-01) -
FKS1 Is Required for Cryptococcus neoformans Fitness In Vivo: Application of Copper-Regulated Gene Expression to Mouse Models of Cryptococcosis
by: Sarah R. Beattie, et al.
Published: (2022-06-01) -
Cryptococcosis: Review
by: A. Lima, et al.
Published: (2013-11-01) -
Cryptococcosis: Review
by: A. Lima, et al.
Published: (2013-11-01) -
Criptococcose cutânea primária em paciente imunocompetente Primay cutaneous cryptococcosis in an immunocompetent patient
by: Nilton Nasser, et al.
Published: (2011-12-01)